Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Saved in:
Bibliographic Details
Title: Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.
Authors: Wade JC, Schimpff SC, Newman KA, Fortner CL, Moody MR, Young VM, Wiernik PH
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1980 Aug; Vol. 18 (2), pp. 299-306.
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN: 0066-4804 (Print) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0066-4804
DOI:10.1128/AAC.18.2.299